Molly Joel Coye

Molly Joel Coye

As Executive in Residence at AVIA, Dr. Coye helps to build networks and strategies that will accelerate the adoption of high-value innovations. In addition, she advises technology developers, investors, national health systems and policy makers about disruptive technologies and business models in healthcare.

Dr. Coye has extensive experience in both the public and private sectors. She served as Commissioner of Health for the State of New Jersey and Director of the California Department of Health Services, in addition to heading the Division of Public Health at the Johns Hopkins School of Hygiene and Public Health, leading marketing and product development for interactive health communication and disease management at HealthDesk Corp, serving as Executive Vice President for the Good Samaritan Health System, and directing The Lewin Group’s West Coast office. Dr. Coye also founded and served as CEO of the Health Technology Center, a non-profit group dedicated to advancing the use of beneficial technologies for healthier people and communities.

As a member of the Institute of Medicine, Dr. Coye co-authored the reports To Err is Human and Crossing the Quality Chasm, chaired the Committee on Access to Insurance for Children, and co-chaired the Committee on Patient Safety Data Standards.

Dr. Coye is on the board of Aetna, Inc., and previously chaired the boards of Prosetta Biosciences, PATH, and the American Public Health Association, and served on the boards of the American Hospital Association, the American Telemedicine Association, ACCESS Health International, Big White Wall, Cholestech, and the China Medical Board. She was a founding board member of The California Endowment, the largest private health care philanthropy in California.

Dr. Coye has her M.D. and M.P.H. degrees from Johns Hopkins University and is board certified by the American College of Preventive Medicine.

In 2005, she was selected one of the 25 most influential women in health care by Modern Healthcare magazine.